Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-806-1 | CAS number: 5089-72-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (WoE, OECD 406/429): sensitising (RA from CAS 1760-24-3 and CAS 3069-29-2)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 16.09.1991 to 19.10.1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test was performed in 1992 when the OECD Guideline 406 adopted in 1992 was the current version. According to this guideline "the Guinea Pig Maximisation Test (GPMT) [...] and the non-adjuvant Buehler Test are given preference over other methods".
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: young adult
- Weight at study initiation: 300-500 g
- Housing: by sex and in groups of up to 5 or 6 (2 for the preliminary studies), in polystyrene cages with perforated flooring
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20±3
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- other: sterile Codex liquid paraffin
- Concentration / amount:
- Intradermal injections: 0.1%
Epicutaneous induction: 10% - No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: sterile Codex liquid paraffin
- Concentration / amount:
- Topical challenge: 10%
- No. of animals per dose:
- Control: 20
Test: 20 - Details on study design:
- Induction
Treated group:
By intradermal route: 3 series of 2 x 0.1 ml injections.
1) FCA at 50% (v/v) in an isotonic injectable solution;
2) test substance in a 0.1% (v/v) solution in sterile Codex liquid paraffin;
3) mixture 50/50 (v/v): test substance in a 0.2% (v/v) in sterile Codex liquid paraffin + FCA at 50% (v/v) in an isotonic injectable solution, i.e. a final 0.1% concentration of the test substance.
By topical occlusive route for 48 hours: with 0.5 ml of the test substance in a 10% (v/v) solution in sterile Codex liquid paraffin. As this application only provoked a weak irritation during the preliminary study, a skin painting was performed on Day 8, with 0.5 ml of sodium lauryl sulfate at 10% (w/w) in Codex paraffin.
Control: The intradermal injections and the topical occlusive application for 48 hours were carried out under the same conditions as in the treated group, sterile Codex liquid paraffin replacing the test substance.
The rest period was 11 days without treatment.
Challenge
Topical occlusive application for 24 hours performed in the treated and control groups with the test substance in a 10% (v/v) solution in
sterile Codex liquid paraffin and at a rate of 0.5 ml. The vehicle was also applied during the challenge.
The cutaneous macroscopic examinations were performed according to Magnusson & Kligman scale and to the challenge application site, 24 and 48 hours after removal of the patches. Histopathological examinations of the skin were performed for nine animals of the treated group that showed doubtful macroscopic reactions at 24 hours and for one animal of the control group, which showed abnormal macroscopic reactions at 24 hours. - Challenge controls:
- The control group is actually a chellenge control.
- Positive control substance(s):
- not specified
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- intradermal induction 0.1 % (v/v); challenge 10% (v/v)
- No. with + reactions:
- 6
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- intradermal induction 0%; challenge 10% (v/v)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- intradermal induction 0.1 % (v/v); challenge 10% (v/v)
- No. with + reactions:
- 6
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- intradermal induction 0%; challenge 10% (v/v)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- In a guinea pig maximisation study conducted to OECD 406 and to GLP the test material provoked a positive reaction in 30% of the test animals. Hence, this test substance is considered to be a skin sensitiser.
Reference
Signs of irritation were noted during the induction.
The macroscopic and histopathological examinations revealed pathological lesions of delayed hypersensitivity in 6 out of the 20 treated animals. A weak irritation was noted in one animal of the control group. No other cutaneous abnormality was noted in the 19 other guinea pigs examined in the control group.
Overall, the test substance provoked a reaction of cutaneous sensitisation in 30% of the animals examined.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
No data are available to assess the skin sensitisation potential of N-[3-(triethoxysilyl)propyl]ethylenediamine (CAS 5089-72-5), however, reliable data are available for the structural analogue substances N-(3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) and 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2).
READ-ACROSS JUSTIFICATION
To reduce animal testing REACH recommends to make use of a read-across approach where appropriate based on the high accordance in properties relevant for the specific endpoint. In the case of skin sensitisation relevant properties are structural similarity as well as physical-chemical and basic toxicological parameters in the same range. In the following paragraphs the read-across approach for N-[3-(triethoxysilyl)propyl]ethylenediamine is evaluated point by point.
Read-across hypothesis
Four skin sensitisation studies (3 GPMT studies and 1 LLNA study) are available for the analogue substances N-[3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) and 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2). All four studies gave clear positive results, thus concluding-[3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) and 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2) to be skin sensitisers.
N-[3-(triethoxysilyl)propyl]ethylenediamine (CAS 5089-72-5), N-[3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) and 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2) have a medium to high dermal absorption potential (40, 20 and 80%, respectively), corresponding to a dermal absorption of 7.79E-03, 7.11E-04 and 4.35E-02 mg/cm²/h, respectively. This prediction was calculated with DERWIN (v2.02.2012) on the basis of molecular weight (264.4, 222.4 and 206.36 g/mol), water solubility (2.4E+04, 1E+06 and 8.6E+05 mg/l), and log Kow (1.2, -1.67 and 1.0).
All three substances could undergo hydrolysis resulting in the common or similar silicon-containing hydrolysis products, N-(3-(trihydroxysilyl)propyl)ethylenediamine or 3-(2-aminoethylamino)propylmethyldihydroxyysilane, respectively. The hydrolysis products are supposed to have a dermal absorption that is higher than that of the parent substances. Since skin penetration is one essential step during skin sensitisation, it is considered appropriate to read-across this result to the other members of the aminofunctional alkoxysilane analogue group. This is supported by a larger data set of skin sensitisation studies for aminofunctional alkoxysilanes (PFA, 2013t). In addition the hydrolysis products methanol and ethanol are not sensitising to skin.
Discussion
There are four good quality skin sensitisation studies, all of which give clear positive results.
The first study is a guinea pig maximisation test, conducted with N-(3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) according to OECD 406 and in compliance with GLP. Animals were intradermally induced with 0.1% test substance solution and epicutaneously induced with 10% test substance solution. Challenge exposure was conducted with 10 % test substance formulation and provoked a positive reaction in 30% of the test animals, concluding the test substance to be a moderate skin sensitiser (Cat 1B according to Regulation (EC) No. 1272/2008) (Hazleton France, 1992).
A further study, also a guinea pig maximisation test, was conducted with N-(3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) according to OECD 406 and in compliance with GLP. Animals were intradermally induced with 0.5% test substance solution and epicutaneously induced with undiluted test substance. Challenge exposure was conducted with neat test substance and provoked a positive reaction in 100% of the test animals, concluding the test substance to be a moderate skin sensitiser (Cat 1B according to Regulation (EC) No. 1272/2008) under the conditions of this test (SafePharm Laboratories Ltd, 1987).
Another study employed a mouse Local Lymph Node Assay, conducted with N-(3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) according to OECD 429 and in compliance with GLP. The stimulation indices for 5, 10, 25 and 50% test substance (in 3+1 (v/v) acetone/olive oil) were 1.7, 2.5, 4.7 and 7.9, respectively. The negative and positive (P-Phenylenediamine) controls gave stimulation indices of 1.0 and 12.1, respectively. Based on these results, the EC3 value was calculated at a concentration of 13% of the test substance. The test substance was therefore a moderate sensitiser (Cat 1B according to Regulation (EC) No. 1272/2008) under the conditions of this test (BSL, 2005).
The skin sensitising study was conducted with 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2) according to OECD 406 and in compliance with GLP. The study for skin sensitisation in guinea pig reports the test substance to be an extreme sensitiser to skin as assessed by a Magnusson & Kligman Maximisation Test (SafePharm Laboratories Ltd., 1988) in accordance with OECD 406 and GLP. 19/20 test animals showed positive responses at both 24 and 48 hour readings.
In conclusion, based on the available data from the structural analogues N-(3-(trimethoxysilyl)propyl]ethylenediamine (CAS 1760-24-3) and 3-(2-aminoethylamino)propylmethyldimethoxysilane (CAS 3069-29-2) it was concluded that the registered substance N-[3-(triethoxysilyl)propyl]ethylenediamine (CAS 5089-72-5) is sensitising to the skin following the weight of evidence approach.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
- Study not required according to Annex VII-X of Regulation (EC) No 1907/2006.
Justification for classification or non-classification
Based on reliable data from the analogue substances N-(3 -(trimethoxysilyl)propyl)ethylenediamine (CAS 1760 -24 -3) and 3-(2-aminoethylamino)propylmethyldimethoxy-silane (CAS 3069-29-2), the registered substance N-(3 -(triethoxysilyl)propyl)ethylenediamine (CAS 5089 -72 -5) is classified as Skin Sens. 1B (H317: May cause an allergic skin reaction) according to Regulation (EC) No. 1272/2008 following the weight of evidence approach.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.